Evaluation of the Benefit of Non-opioid General Anaesthesia on Postoperative Pain in Laparoscopic Colonic Surgery
AGORA
1 other identifier
interventional
160
1 country
1
Brief Summary
Evaluation of the benefit of non-opioid general anaesthesia on postoperative pain in laparoscopic colonic surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 17, 2020
CompletedFirst Submitted
Initial submission to the registry
August 16, 2021
CompletedFirst Posted
Study publicly available on registry
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2023
CompletedDecember 18, 2023
December 1, 2023
2.2 years
August 16, 2021
December 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Morphine Use
All intravenous and oral morphine consumed in the first 48 hours after surgery
48 hours
Secondary Outcomes (26)
Postoperative pain H12
Hour 12
Postoperative pain H24
Hour 24
Postoperative pain H36
Hour 36
Postoperative pain H48
Hour 48
Postoperative pain D30
Day 30
- +21 more secondary outcomes
Study Arms (2)
Group with morphine
ACTIVE COMPARATORconventional general anaesthesia with morphine
Group without opiates
EXPERIMENTALgeneral anaesthesia without opiates
Interventions
Anaesthesia without opiates for patients undergoing laparoscopic colectomy
anaesthesia with morphine for patients undergoing laparoscopic colectomy
Eligibility Criteria
You may qualify if:
- Patient over 18 years of age who has read and signed the consent form for participation in the study
- Patient candidate for laparoscopic colectomy (planned or emergency) with possible conversion to laparotomy
You may not qualify if:
- Severe renal failure with baseline clearance\<30, hepatic failure with baseline PT\<40%, cardiac failure with LVEF\<20%.
- Patient under court protection, guardianship or curatorship
- Pregnant or breastfeeding patient
- Patient not affiliated to the French social security system
- Impossible to give the subject informed information and/or to give written informed consent: dementia, psychosis, disturbed consciousness, non-French speaking patient
- Contraindication to anaesthesia or to the administration of one of the products used in the anaesthesia protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Privé Médipôle
Villeurbanne, 69100, France
Related Publications (1)
Collange V, Berruet JB, Aubrun F, Poiblanc M, Olagne E, Golliet Mercier N, Parent S, Noel P, Devillez S, Perrou M, Ramadan J, Coeckelenbergh S, Joosten A. Opioid free versus opioid sparing strategies for multimodal antinociception during laparoscopic colectomy: a randomised controlled trial. Anaesth Crit Care Pain Med. 2024 Dec;43(6):101436. doi: 10.1016/j.accpm.2024.101436. Epub 2024 Oct 9.
PMID: 39393528DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The patient does not know which treatment is used for the anesthesia
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2021
First Posted
September 1, 2021
Study Start
December 17, 2020
Primary Completion
February 17, 2023
Study Completion
February 17, 2023
Last Updated
December 18, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share